Search
forResearch 10 of 1000+
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Health‐related quality of life of adult and adolescent patients living with alopecia areata in Australia
- CO149 Does the EQ-5D Measure the Full Impact of Alopecia Areata on Patients' Health Related Quality of Life?
- Hair
- Overcoming Curcumin's Limitations: Synthetic Derivatives in Diabetes and Cancer Management
- In vitro bioassays for androgens and their diagnostic applications
- Assessment of clinician-reported outcome measures for alopecia areata: a systematic scoping review
- Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models
- Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
- Analyzing signaling activity and function in hematopoietic cells
Community 7 of 53
- Oral Minoxidil appears to work substantially better in patients with low SULT1A1 enzyme activity
- Tretinoin vs. micro-needling: what increases sulfotransferase activity more?
- Increasing activity of the sult1a1 enzyme via alkalizing agent and tretinoin for better response to topical minoxidil
- Research: Minoxidil grows hair by suppressing androgen activity (DHT) in hair follicles.
- Do the more newer gen topical retinoids e.g. tazarotene outperform tretinoin in inducing follicular sulfotransferase activity?
- Other sulfurtransferase activity upregulator other than Tretinoin?
- Minoxidil + Tretinoin if you suspect you have low sulfotransferase enzyme activity
Learn
— no results
Try a deeper search in learn →